The Prognostic Significance of Beta2 Microglobulin in Patients with Hemophagocytic Lymphohistiocytosis

<div>Serum <i>β</i><sub>2</sub>-m concentrations in the 41 patients with lymphoma associated hemophagocytic syndrome (LAHS), the 33 patients with benign disease-associated hemophagocytic lymphohistiocytosis (HLH) and 35 controls.</div>

Disease Markers

fig1

Figure 1

Figure 1: The Prognostic Significance of Beta2 Microglobulin in Patients with Hemophagocytic Lymphohistiocytosis 